Suppr超能文献

克莱恩费尔特综合征青少年男性乳房发育症的发生率和睾酮治疗的结果。

Incidence of gynaecomastia in Klinefelter syndrome adolescents and outcome of testosterone treatment.

机构信息

Department of Paediatric and Adolescent Endocrinology, University College London Hospital, 250 Euston Road, London, NW1 2PQ, UK.

UCL Great Ormond Street Institute of Child Health, London, UK.

出版信息

Eur J Pediatr. 2021 Oct;180(10):3201-3207. doi: 10.1007/s00431-021-04083-2. Epub 2021 May 2.

Abstract

The aim was to define the true incidence of gynaecomastia in adolescent boys with Klinefelter syndrome (KS) and to observe testosterone treatment effects on its duration by examination of the prospectively collected data from a specialist referral clinic for boys with KS, with comparison being made with KS boys identified by a historical newborn chromosome screening programme, together with chromosomally normal controls. Fifty-nine boys over age 13 years were referred to a specialist KS clinic; 21 developed gynaecomastia. The comparator was 14 KS boys identified at birth and 94 chromosomally normal control boys. Testosterone was routinely started at the onset of puberty if gynaecomastia, a manifestation of clinical hypogonadism, was present. Oral or transdermal testosterone was administered in the morning, in a reverse physiological rhythm, and doses were increased according to standard pubertal regimens. The incidence of gynaecomastia was not increased in both the KS cohorts compared with controls. The incidence and age of onset of gynaecomastia was 35.6%, at 12.3 (1.8) years in the KS clinic group; 36.0%, at 13.7 (0.6) years in the newborn survey group; and 34.0%, at 13.6 (0.8) years in the controls. Full resolution of the gynaecomastia occurred in the 12/14 KS clinic boys on testosterone treatment who had completed puberty and as long as adherence was maintained.Conclusion: The incidence of gynaecomastia in KS boys (overall 35.6%) is not increased over typically developing boys. Commencing testosterone when gynaecomastia develops with physiological dose escalation and full adherence can result in the resolution of the gynaecomastia. What is Known: • Gynaecomastia is a common feature in Klinefelter syndrome men. • Hypogonadism occurs from mid-puberty onwards with the absence of the usual rise in testosterone levels. What is New: • The incidence of pubertal gynaecomastia in Klinefelter syndrome is not different from typically developing boys. • Early and prompt starting of testosterone gel treatment and increasing the dose physiologically may help to resolve the gynaecomastia without the need for surgery.

摘要

目的是确定 Klinefelter 综合征(KS)青少年男性中男性乳房发育的真实发病率,并通过对 KS 专科转诊诊所的前瞻性数据进行检查,观察睾酮治疗对其持续时间的影响,该诊所的患者为 KS 男孩,同时与通过历史新生儿染色体筛查计划确定的 KS 男孩和染色体正常的对照组进行比较。59 名年龄在 13 岁以上的男孩被转介到 KS 专科诊所;其中 21 名出现男性乳房发育。对照者为 14 名出生时即被确诊为 KS 的男孩和 94 名染色体正常的对照组男孩。如果出现男性乳房发育(临床性腺功能减退的表现),则常规在青春期开始时给予睾酮治疗。口服或透皮给予睾酮,在早晨按照反生理节律给药,并根据标准青春期方案增加剂量。与对照组相比,在两个 KS 队列中,男性乳房发育的发病率并未增加。KS 诊所组男性乳房发育的发病率和发病年龄为 35.6%,发病年龄为 12.3(1.8)岁;新生儿调查组为 36.0%,发病年龄为 13.7(0.6)岁;对照组为 34.0%,发病年龄为 13.6(0.8)岁。在接受睾酮治疗的 12/14 名 KS 诊所男孩中,只要坚持治疗,男性乳房发育完全消退。结论:KS 男孩(总体为 35.6%)的男性乳房发育发病率并未高于正常发育的男孩。当男性乳房发育出现时,开始给予生理剂量递增的睾酮治疗,并保持完全依从性,可使男性乳房发育得到解决。已知:• 男性乳房发育是 Klinefelter 综合征男性的常见特征。• 从中青春期开始出现性腺功能减退,而睾酮水平通常不会升高。新发现:• Klinefelter 综合征青春期男性乳房发育的发病率与正常发育男孩无差异。• 早期和及时开始使用睾酮凝胶治疗,并生理性地增加剂量,可能有助于解决男性乳房发育问题,而无需手术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验